Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure

Mark G. Lebwohl*, Joseph F. Merola, Katelyn Rowland, Megan Miller, Ya Wen Yang, Jenny Yu, Yin You, Daphne Chan, Diamant Thaçi, Richard G. Langley

*Corresponding author for this work
5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure'. Together they form a unique fingerprint.

Medicine & Life Sciences